Cinova Medical announced the acquisition of Elastomer Technologies, Inc. (ETI), a Southern California–based custom molder of liquid silicone rubber (LSR) and high-consistency gum rubbers serving the medical device and life sciences industries. ETI will continue operating from its current facility while Cinova Medical completes the expansion of a new Class 8 cleanroom dedicated to silicone molding. Upon completion, ETI’s manufacturing operations will be integrated into Cinova’s expanded production footprint. Headquartered in Phoenix, AZ, Cinova Medical is a vertically integrated contract manufacturer of precision-engineered, high-quality injection-molded and machined components, as well as complex Class II finished (sterile) medical devices.
Image courtesy of Cinova Medical
Since 2023, Cinova Medical has acquired three separate manufacturing businesses in Phoenix, Arizona, underscoring the company’s commitment to strengthening its position as a leading, vertically integrated contract manufacturing organization (CMO). This latest acquisition marks Cinova’s fourth transaction in less than three years. Cinova has tripled its growth during this time and continues to support the Arizona initiative of becoming Top 10 Life Science state.
“Phoenix is leading the way in bioscience and medical manufacturing innovation,” Phoenix Mayor Kate Gallego said. “Cinova Medical’s expansion strengthens our growing bioscience sector while helping deliver high quality, lifesaving technologies to patients around the world.”
About Elastomer Technologies, Inc. (ETI)
Headquartered in Corona, CA, ETI is an ISO 13485:2016-certified company supporting several of the world’s leading medical device manufacturers with critical, life-sustaining molded and over-molded components. The company specializes in injection, transfer, and compression molding, complemented by comprehensive elastomeric die-cutting services.
About Cinova Medical
Headquartered in Phoenix, AZ, Cinova Medical is a vertically integrated contract manufacturer of precision-engineered, high-quality injection-molded and machined components, as well as complex Class II finished (sterile) medical devices. Its customer base ranges from early-stage medical device startups to some of the world’s largest medical technology companies. As an FDA-registered and ISO 13485:2016-certified organization, Cinova maintains quality systems aligned with the rigorous standards established by the U.S. Food and Drug Administration, ensuring regulatory compliance and product integrity at every stage of production.
SOURCE: Cinova Medical